Connect with us
A study published Monday with the Lancet medical journal found that people who were bedridden for 7 days or more with COVID-19 were more likely to experience...
The World Health Organization said Wednesday that it advises the use of molnupiravir for high-risk COVID-19 patients. Molnupiravir is an antiviral COVID-19 pill developed by Merck...
Researchers found that a previous infection may be more beneficial than vaccination against COVID-19 because the former may produce better-performing antibodies. Better Protection In a new...
More data on the omicron variant are slowly trickling in as scientists and medical experts continue to examine the strain rapidly spreading in many parts of...
While the world is on the lookout for possible surges amid the emergence of the omicron variant, early reports appear to suggest that the newer strain does...
The common antidepressant fluoxetine, that is sold under the brand name Prozac, was recently found to lower the death risk of patients suffering severe COVID-19 infection. ...
A new pill could soon provide a cure for COVID-19 and significantly slow the spread of the novel coronavirus all at once. Experts are now looking at...
A new study is shedding more light on what could be causing severe COVID-19 infection in SARS-CoV-2 patients. Stanford researchers revealed this week their interesting discovery...
Alabama and Arkansas are already at capacity as the Delta variant spreads in the South. Read More
The pace of acute therapy and vaccine development for COVID have been dizzying. But even as we hope a route to bringing the pandemic under control...
Recent Comments